Coromandel International Strong FY26 Growth Momentum and Strategic Expansion

Coromandel International reported a robust performance for the fiscal year ending March 31, 2026, with a 30% increase in consolidated total income reaching Rs 31,827 crore. Despite a challenging global environment, the company maintained steady growth in its Nutrient and Crop Protection segments. Strategic investments in backward integration, including new Sulphuric and Phosphoric Acid plants in Kakinada, and an expanded retail footprint of 1,200 centers, underscore the company’s commitment to sustainable agricultural productivity.

Financial Performance Overview

For the full fiscal year 2026, Coromandel International achieved a consolidated total income of Rs 31,827 crore, reflecting a 30% growth compared to the previous year. EBITDA for the same period stood at Rs 3,232 crore, a 23% rise. While the fourth quarter (Jan-Mar) faced some headwinds, the company’s full-year performance reflects resilience in navigating volatile raw material prices and supply chain disruptions.

Strategic Growth and Infrastructure

The company successfully enhanced its backward integration capabilities with the commissioning of a 2,000 TPD Sulphuric Acid plant and a 650 TPD Phosphoric Acid plant at Kakinada. Representing an investment of ~Rs 1,100 crore, these assets are designed to secure long-term raw material supply. Furthermore, the Nutrient business achieved sales of 4.3 million tons, marking a 7% growth in the phosphatic fertiliser segment.

Segment Highlights

The Crop Protection business emerged as a key growth driver, recording 16% revenue growth and a significant 55% increase in profitability. This success was attributed to sustained traction in key technical molecules, export volume offtake, and successful new product launches in domestic markets. Additionally, the company’s Agri Retail network continued its expansion, reaching 1,200 centers, with 300 new stores added during the fiscal year.

Shareholder Returns

Reflecting its strong cash flow and financial health, the Board has approved a final dividend of Rs 2 per share. When combined with the Rs 9 per share interim dividend paid in February 2026, the total dividend for the year amounts to Rs 11 per equity share, equivalent to 1,100% on the face value of Rs 1.

Source: BSE

Previous Article

Emami Limited Strategic Stake Acquisition in IncNut Digital Private Limited